SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Canaccord Genuity Maintains Buy on ChemoCentryx, Lowers Price Target to $58

Canaccord Genuity maintains ChemoCentryx (NASDAQ:CCXI) with a Buy and lowers the price target from $68 to $58.

Benzinga · 05/19/2020 15:35

Canaccord Genuity maintains ChemoCentryx (NASDAQ:CCXI) with a Buy and lowers the price target from $68 to $58.